Multiple Endocrine Neoplasia Type 1
Showing 1 - 25 of >10,000
Natural History Study of Parathyroid Disorders
Recruiting
- Parathyroid Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)
Recruiting
- Multiple Endocrine Neoplasia Type 1
- Pancreatic Neuroendocrine Tumor
- EUS-guided fine-needle injection
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 24, 2022
Study and Monitoring of Multiple Endocrine Neoplasia Type 1
Recruiting
- MEN1
- Questionnaires
-
Dijon, FranceCHU Dijon Bourgogne
Jan 4, 2022
Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided
Recruiting
- Neuroendocrine Tumor of Pancreas
- Multiple Endocrine Neoplasia Type 1
- High-dose-high precision MR-guided radiotherapy
-
Utrecht, NetherlandsUMC Utrecht
May 29, 2022
MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)
Not yet recruiting
- MEN1 Gene Mutation
- Leflunomide 20 mg
-
Basel, SwitzerlandUnispital Basel
Nov 1, 2022
Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston
Recruiting
- Advanced Carcinoid Tumor
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Familial Investigations of Childhood Cancer Predisposition
Recruiting
- Acute Leukemia
- +45 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 11, 2022
Routine Transcervical Thymectomy in MEN-1 Patients
Completed
- Multiple Endocrine Neoplasia Type 1 (MEN-1)
- Thymic Carcinoid
- Routine thymectomy, which has been performed
-
Singapore, SingaporeNational University Hospital
Sep 25, 2021
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Meningioma, Metastatic Well Differentiated Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston (Computed
Terminated
- Meningioma
- +5 more
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 11, 2021
A Retrospective Study for Multiple Endocrine Neoplasia
Recruiting
- Multiple Endocrine Neoplasia
- no intervention
-
Taipei, TaiwanNational Taiwan University Hospital
Apr 2, 2023
Studies of Inherited Diseases of Metabolism
Completed
- Multiple Endocrine Neoplasia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Hyperparathyroidism, Hypercalcemia, Parathyroid Tumor Trial run by the NIDDK (68Ga-Dotatate, 18F-DOPA)
Completed
- Hyperparathyroidism
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 12, 2022
Genetic Factors and Pheochromocytomas in Neoplasia Type 2
Recruiting
- Neoplasia
- Pheochromocytoma
-
Marseille, FranceAPHM - Hôpital de la Conception
Jan 30, 2022
Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Carcinoma Trial in Tampa, Houston (radiation, other, biological)
Completed
- Multiple Endocrine Neoplasia Type 1
- Pancreatic Neuroendocrine Carcinoma
- Computed Tomography Perfusion Imaging
- +2 more
-
Tampa, Florida
- +2 more
Mar 18, 2020
Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in
Completed
- Gastrin-Producing Neuroendocrine Tumor
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 25, 2020
Endocrine Hormones to Hypoglycemia in Type 1 or Type 2 Diabetes
Completed
- Diabetes
- The hyperinsulinaemic hypoglycaemic clamp
-
Nanjing, ChinaNanjing First Hospital, Nanjing Medical Univesity
Oct 10, 2022
Pituitary ACTH Hypersecretion, Acromegaly, Diabetes, Type 1 Trial in Moscow (Cholecalciferol 15000 UNT/ML Oral Solution)
Completed
- Pituitary ACTH Hypersecretion
- +3 more
- Cholecalciferol 15000 UNT/ML Oral Solution
-
Moscow, Russian FederationEndocrinology Research Centre, Moscow
Aug 10, 2022
Type 1 Diabetes, Metabolic Disease, Endocrine System Diseases Trial (Support platform)
Not yet recruiting
- Type 1 Diabetes
- +4 more
- Support platform
- (no location specified)
Sep 29, 2023
Type2diabetes Trial in Nasiriyah, Basrah (Insulin Glargine 100 UNT/ML Pen Injector [Lantus], Saxagliptin 2.5 mg/ Metformin
Not yet recruiting
- Type2diabetes
- Insulin Glargine 100 UNT/ML Pen Injector [Lantus]
- +2 more
-
Nasiriyah, Thi Qar, Iraq
- +1 more
Oct 28, 2023
Endocrine Neoplasia Trial in Houston (4-[18F]Fluoro-1-Naphthol)
Recruiting
- Endocrine Neoplasia
-
Houston, TexasMD Anderson Cancer Center
Nov 16, 2022
Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI
Completed
- Medullary Thyroid Carcinoma
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 1, 2020
Diabetes, Metabolic Disease, Glucose Metabolism Disorders Trial in Bern (Device: Sokru device)
Active, not recruiting
- Diabetes Mellitus
- +3 more
- Device: Sokru device
-
Bern, SwitzerlandUniversity of Bern
Jun 26, 2023
Adrenal and Other Endocrine Tumors in Patients With Sudden Death
Recruiting
- Primary Aldosteronism
- +3 more
- Adrenal aldosterone synthase (CYP11B2) staining
- +2 more
-
Helsinki, FinlandEndocrinology, Helsinki University Hospital and University of He
Jul 8, 2022